Economic evaluations of cancer immunotherapy: a systematic review and quality evaluation

Cancer Immunology, Immunotherapy : CII
Charlotte CouchoudVirginie Nerich

Abstract

Scientific advances in the last decade have highlighted the use of immunotherapy, especially immune checkpoint inhibitors, to be an effective strategy in cancer therapy. However, these immunotherapeutic agents are expensive, and their use must take into account economic criteria. Thus, the objective of the present study was to systematically identify and review published EE related to the use of ipilimumab, nivolumab or pembrolizumab in melanoma, lung cancer, head and neck cancer or renal cell carcinoma, and to assess their quality. The systematic literature research was conducted on Medline via PubMed and the Cochrane Central Register of Controlled Trials to identify economic evaluations published before July 2018. The quality of each selected economic evaluation was assessed by two independent reviewers using the Drummond checklist. Our systematic review was based on 32 economic evaluations using different methodological approaches, different perspectives and different time horizons. Three-quarters of the economic evaluations are full (n = 24) with a Drummond score ≥ 7, synonymous of "high quality". Among them, 66% reported a strategy that was cost-effective. The most assessed immunotherapeutic agent was nivolumab. In patient...Continue Reading

References

Mar 22, 1996·Science·D R LeachJ P Allison
Jan 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Julia A BrownGordon J Freeman
Feb 17, 2007·BMC Medical Research Methodology·Beverley J SheaLex M Bouter
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Nov 3, 2010·British Medical Bulletin·Sarah J Whitehead, Shehzad Ali
Aug 29, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·O J Finn
Oct 13, 2012·Journal of Medical Economics·Victor BarzeyJohn R Penrod
Mar 21, 2013·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Anthony JarkowskiNikhil I Khushalani
Mar 30, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Don HusereauUNKNOWN ISPOR Health Economic Evaluation Publication Guidelines-CHEERS Good Reporting Practices Task Force
Apr 11, 2015·Melanoma Research·Nadia YousafJames Larkin
Apr 18, 2015·Melanoma Research·Chun-Lan ChangYeun Mi Yim
Apr 22, 2015·The New England Journal of Medicine·Caroline RobertUNKNOWN KEYNOTE-006 investigators
Jun 2, 2015·The New England Journal of Medicine·James LarkinJedd D Wolchok
Jun 2, 2015·The New England Journal of Medicine·Julie BrahmerDavid R Spigel
Jun 24, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lowell E Schnipper American Society of Clinical Oncology
Sep 26, 2015·The New England Journal of Medicine·Robert J MotzerUNKNOWN CheckMate 025 Investigators
Sep 29, 2015·The New England Journal of Medicine·Hossein BorghaeiJulie R Brahmer
Oct 25, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Klazien Matter-WalstraUNKNOWN Swiss Group for Clinical Cancer Research
Aug 20, 2016·Drugs in Context·Ivar S JensenWes Yin
Oct 11, 2016·The New England Journal of Medicine·Robert L FerrisMaura L Gillison
Dec 19, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Megan A BohenskyDanny Liew
Jan 27, 2017·Journal of Managed Care & Specialty Pharmacy·Jingshu WangFrank Xiaoqing Liu
Feb 22, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christine G KohnChristopher R Flowers
Jun 22, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P N AguiarG L Lopes
Jul 14, 2017·International Journal of Technology Assessment in Health Care·Alberto RussiAngelo Claudio Palozzo
Aug 16, 2017·European Urology·Michal SarfatyDaniel A Goldstein
Oct 2, 2017·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Luis Silva MiguelPedro Almeida Laires
Nov 7, 2017·Oral Oncology·Matthew C WardMendel E Singer
Feb 20, 2018·Experimental Hematology & Oncology·Charles McCreaJustin Doan
Mar 11, 2018·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Yang MengDawn Lee
Mar 27, 2018·European Urology·Michal SarfatyDaniel A Goldstein
Mar 29, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David J VaughnRonald de Wit
May 5, 2018·American Journal of Clinical Oncology·Jacques RaphaelDavid M Naimark

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Jennifer G GaultneyCarin A Uyl-de Groot
International Journal of Technology Assessment in Health Care
Lidia García-PérezPedro Serrano-Aguilar
Plastic and Reconstructive Surgery
Natalia I ZiolkowskiAchilleas Thoma
Applied Health Economics and Health Policy
Shankar PrinjaStephen Jan
© 2021 Meta ULC. All rights reserved